Tumor-induced osteomalacia: The tumor may stay hidden!

[en] We report the case of a patient with severe muscular and articular tenderness that caused almost complete immobility. This subject had severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth factor 23 (FGF-23) was abnormally high and the diagnostic of tumor-induced osteomalacia was made. Despite multiple tests, the tumor was not localized. In this report, we discuss different possible investigations to localize the tumor. Lastly, we review the potential therapy available when tumor is not found and can thus not be excised.

Disciplines :

Laboratory medicine & medical technology

Author, co-author :

VAN DER REST, Catherine

CAVALIER, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale

KAUX, Jean-François ; Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur

KRZESINSKI, Jean-Marie ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

HUSTINX, Roland ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire

REGINSTER, Jean-Yves ; Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur

DELANAYE, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Language :

English

Title :

Tumor-induced osteomalacia: The tumor may stay hidden!

Publication date :

October 2011

Journal title :

Clinical Biochemistry

ISSN :

0009-9120

eISSN :

1873-2933

Publisher :

Elsevier Science, Tarrytown, United States - New York

Volume :

Issue :

14-15

Pages :

1264-6

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 08 September 2011

Statistics

Number of views

102 (18 by ULiège)

Number of downloads

17 (6 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Prie D., Friedlander G. Genetic disorders of renal phosphate transport. N Engl J Med 2010, 362:2399-2409.
Filler G., Liu D., Huang S.H., Casier S., Chau L.A., Madrenas J. Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease. Clin Biochem 2011, 44:435-437.
Seufert J., Ebert K., Muller J., et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001, 345:1883-1888.
Radaideh A.R., Jaradat D., Abu-Kalaf M.M., Nusier M.K. Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft-tissue tumour. Curr Oncol 2009, 16:87-90.
Hannan F.M., Athanasou N.A., Teh J., Gibbons C.L., Shine B., Thakker R.V. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol 2008, 158:265-271.
Dupond J.L., Mahammedi H., Prie D., et al. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case. Bone 2005, 36:375-378.
Takeuchi Y., Suzuki H., Ogura S., et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004, 89:3979-3982.
van Boekel G., Ruinemans-Koerts J., Joosten F., Dijkhuizen P., van Sorge A., de Boer H. Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol 2008, 158:431-437.
Andreopoulou P., Dumitrescu C.E., Kelly M.H., et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res 2011, 26:1295-1302.
Kimizuka T., Ozaki Y., Sumi Y. Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia. Ann Nucl Med 2004, 18:63-67.
Hesse E., Moessinger E., Rosenthal H., et al. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res 2007, 22:158-162.
Michaut P., Prie D., Amiel C., Friedlander G. Dipyridamole for renal phosphate leak?. N Engl J Med 1994, 331:58-59.
Geller J.L., Khosravi A., Kelly M.H., Riminucci M., Adams J.S., Collins M.T. Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res 2007, 22:931-937.